Related Experiment Videos
Plasmodium vivax malaria presenting with severe thrombocytopenia
Ravinder Pal Singh Makkar1, Surabhi Mukhopadhyay, Amitabh Monga
1Department of Internal Medicine, Sitaram Bhartia Institute of Science ans Research, New Delhi, India. makkar_r@yahoo.com
Summary
Severe thrombocytopenia, a rare complication, was observed in a case of isolated Plasmodium vivax malaria. This finding is significant as profound low platelet counts are typically associated with Plasmodium falciparum malaria.
Area of Science:
- Tropical medicine
- Hematology
- Infectious diseases
Background:
- Malaria, caused by Plasmodium parasites, is a significant public health concern in India, with Plasmodium falciparum and Plasmodium vivax being the most prevalent species.
- Hematological abnormalities, particularly mild thrombocytopenia (low platelet count), are frequently observed in malaria patients.
- Severe thrombocytopenia is a known complication of Plasmodium falciparum malaria and mixed infections, but it is exceptionally rare in isolated Plasmodium vivax malaria.
Observation:
- This report details a rare case of severe thrombocytopenia, with a platelet count as low as 8x10(9)/L, in a patient with isolated Plasmodium vivax malaria.
- The patient presented with symptoms consistent with malaria, and diagnostic tests confirmed the presence of Plasmodium vivax without concurrent Plasmodium falciparum infection.
Findings:
- The case highlights that severe thrombocytopenia can occur in isolated Plasmodium vivax malaria, challenging the conventional understanding of its clinical spectrum.
- This represents only the second documented instance of such profound thrombocytopenia in a patient with exclusively P. vivax infection in the existing medical literature.
Implications:
- This case underscores the need for vigilant monitoring of platelet counts in all malaria patients, irrespective of the Plasmodium species identified.
- Further research is warranted to elucidate the mechanisms underlying severe thrombocytopenia in isolated P. vivax malaria and to refine clinical management guidelines.
- Clinicians should consider severe thrombocytopenia as a potential complication of P. vivax malaria, even in the absence of P. falciparum co-infection.